Molecular Partners AG (MOLN)
5.42
+0.22
(+4.23%)
USD |
NASDAQ |
Nov 21, 16:00
5.34
-0.08
(-1.48%)
After-Hours: 20:00
Molecular Partners Market Cap: 199.66M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 199.66M |
| November 20, 2024 | 191.55M |
| November 19, 2024 | 201.13M |
| November 18, 2024 | 214.76M |
| November 15, 2024 | 196.34M |
| November 14, 2024 | 193.39M |
| November 13, 2024 | 202.97M |
| November 12, 2024 | 209.60M |
| November 11, 2024 | 214.33M |
| November 08, 2024 | 228.39M |
| November 07, 2024 | 222.13M |
| November 06, 2024 | 229.86M |
| November 05, 2024 | 211.81M |
| November 04, 2024 | 223.10M |
| November 01, 2024 | 225.44M |
| October 31, 2024 | 197.45M |
| October 30, 2024 | 226.55M |
| October 29, 2024 | 228.39M |
| October 28, 2024 | 214.43M |
| October 25, 2024 | 215.43M |
| October 24, 2024 | 199.83M |
| October 23, 2024 | 188.19M |
| October 22, 2024 | 218.08M |
| October 21, 2024 | 225.06M |
| October 18, 2024 | 161.65M |
| Date | Value |
|---|---|
| October 17, 2024 | 165.31M |
| October 16, 2024 | 164.31M |
| October 15, 2024 | 164.31M |
| October 14, 2024 | 157.67M |
| October 11, 2024 | 157.67M |
| October 10, 2024 | 157.67M |
| October 09, 2024 | 162.86M |
| October 08, 2024 | 162.86M |
| October 07, 2024 | 158.00M |
| October 04, 2024 | 166.63M |
| October 03, 2024 | 152.03M |
| October 02, 2024 | 153.69M |
| October 01, 2024 | 159.00M |
| September 30, 2024 | 168.86M |
| September 27, 2024 | 168.29M |
| September 26, 2024 | 155.68M |
| September 25, 2024 | 153.36M |
| September 24, 2024 | 166.47M |
| September 23, 2024 | 157.01M |
| September 20, 2024 | 155.02M |
| September 19, 2024 | 155.02M |
| September 18, 2024 | 160.66M |
| September 17, 2024 | 168.63M |
| September 16, 2024 | 172.94M |
| September 13, 2024 | 173.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
109.12M
Minimum
Apr 19 2024
1.030B
Maximum
Jan 14 2022
306.50M
Average
215.51M
Median
Market Cap Benchmarks
| AC Immune SA | 325.52M |
| CRISPR Therapeutics AG | 3.951B |
| Addex Therapeutics Ltd | 8.667M |
| NLS Pharmaceutics Ltd | 12.84M |
| MoonLake Immunotherapeutics | 3.270B |
Market Cap Related Metrics
| PS Ratio | 26.32 |
| PEG Ratio | -0.3296 |
| Price to Book Value | 1.210 |
| Price | 5.42 |
| Earnings Yield | -39.51% |
| PEGY Ratio | -0.3296 |